A detailed history of Financial Perspectives, Inc transactions in Amgen Inc stock. As of the latest transaction made, Financial Perspectives, Inc holds 3,479 shares of AMGN stock, worth $992,976. This represents 0.39% of its overall portfolio holdings.

Number of Shares
3,479
Previous 3,478 0.03%
Holding current value
$992,976
Previous $1.09 Billion 3.16%
% of portfolio
0.39%
Previous 0.4%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$309.38 - $337.38 $309 - $337
1 Added 0.03%
3,479 $1.12 Billion
Q2 2024

Aug 09, 2024

BUY
$262.75 - $319.31 $525 - $638
2 Added 0.06%
3,478 $1.09 Billion
Q1 2024

Apr 19, 2024

SELL
$268.87 - $324.56 $8,334 - $10,061
-31 Reduced 0.88%
3,476 $988 Million
Q4 2023

Feb 01, 2024

BUY
$255.7 - $288.46 $511 - $576
2 Added 0.06%
3,507 $1.01 Billion
Q3 2023

Jan 09, 2024

BUY
$218.65 - $271.46 $5,903 - $7,329
27 Added 0.78%
3,505 $942 Million
Q2 2023

Jan 09, 2024

BUY
$214.27 - $253.37 $428 - $506
2 Added 0.06%
3,478 $772 Million
Q1 2023

Jan 09, 2024

BUY
$225.79 - $275.2 $903 - $1,100
4 Added 0.12%
3,476 $840 Million
Q4 2022

Jan 09, 2024

BUY
$229.03 - $291.01 $458 - $582
2 Added 0.06%
3,472 $912 Million
Q3 2022

Jan 09, 2024

BUY
$224.46 - $253.15 $48,932 - $55,186
218 Added 6.7%
3,470 $782 Million
Q2 2022

Jan 09, 2024

BUY
$230.71 - $256.74 $692 - $770
3 Added 0.09%
3,252 $791 Million
Q1 2022

Jan 09, 2024

BUY
$219.27 - $242.57 $219 - $242
1 Added 0.03%
3,249 $786 Million
Q4 2021

Jan 09, 2024

BUY
$198.88 - $227.6 $397 - $455
2 Added 0.06%
3,248 $731 Million
Q3 2021

Jan 09, 2024

BUY
$212.27 - $248.7 $212 - $248
1 Added 0.03%
3,246 $690 Million
Q2 2021

Jan 09, 2024

SELL
$233.58 - $259.14 $188 Million - $208 Million
-803,885 Reduced 99.6%
3,245 $791 Million
Q1 2021

Jan 09, 2024

BUY
$221.91 - $258.6 $178 Million - $208 Million
803,485 Added 22043.48%
807,130 $3.24 Million
Q4 2020

Jan 09, 2024

BUY
$216.38 - $257.67 $11,251 - $13,398
52 Added 1.45%
3,645 $838 Million
Q3 2020

Jan 09, 2024

BUY
$234.65 - $260.95 $234 - $260
1 Added 0.03%
3,593 $913 Million
Q2 2020

Jan 09, 2024

BUY
$197.81 - $242.74 $395 - $485
2 Added 0.06%
3,592 $847 Million
Q1 2020

Jan 09, 2024

BUY
$182.24 - $241.7 $9,476 - $12,568
52 Added 1.47%
3,590 $728 Million
Q4 2019

Jan 09, 2024

BUY
$189.21 - $243.2 $669,424 - $860,441
3,538 New
3,538 $853 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $153B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Financial Perspectives, Inc Portfolio

Follow Financial Perspectives, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Perspectives, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Perspectives, Inc with notifications on news.